{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:19:30Z","timestamp":1770290370215,"version":"3.49.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T00:00:00Z","timestamp":1382918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T00:00:00Z","timestamp":1382918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms3697","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T10:07:15Z","timestamp":1382954835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets"],"prefix":"10.1038","volume":"4","author":[{"given":"Ana Rita","family":"Carlos","sequence":"first","affiliation":[]},{"given":"Jose Miguel","family":"Escandell","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Kotsantis","sequence":"additional","affiliation":[]},{"given":"Natsuko","family":"Suwaki","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Bouwman","sequence":"additional","affiliation":[]},{"given":"Sophie","family":"Badie","sequence":"additional","affiliation":[]},{"given":"Cecilia","family":"Folio","sequence":"additional","affiliation":[]},{"given":"Javier","family":"Benitez","sequence":"additional","affiliation":[]},{"given":"Gonzalo","family":"Gomez-Lopez","sequence":"additional","affiliation":[]},{"given":"David G.","family":"Pisano","sequence":"additional","affiliation":[]},{"given":"Jos","family":"Jonkers","sequence":"additional","affiliation":[]},{"given":"Madalena","family":"Tarsounas","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,10,28]]},"reference":[{"key":"BFncomms3697_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrm1987","volume":"7","author":"J Gil","year":"2006","unstructured":"Gil, J. & Peters, G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7, 667\u2013677 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFncomms3697_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/labinvest.3780230","volume":"81","author":"N Burri","year":"2001","unstructured":"Burri, N. et al. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab. Invest. 81, 217\u2013229 (2001).","journal-title":"Lab. Invest."},{"key":"BFncomms3697_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s004010000343","volume":"101","author":"T Watanabe","year":"2001","unstructured":"Watanabe, T., Nakamura, M., Yonekawa, Y., Kleihues, P. & Ohgaki, H. Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas. Acta Neuropathol. 101, 185\u2013189 (2001).","journal-title":"Acta Neuropathol."},{"key":"BFncomms3697_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1023\/A:1010686518990","volume":"65","author":"GH Ho","year":"2001","unstructured":"Ho, G. H. et al. Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma. Breast Cancer Res. Treat. 65, 225\u2013232 (2001).","journal-title":"Breast Cancer Res. Treat."},{"key":"BFncomms3697_CR5","first-page":"417","volume":"60","author":"K Ichimura","year":"2000","unstructured":"Ichimura, K. et al. Deregulation of the p14ARF\/MDM2\/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res. 60, 417\u2013424 (2000).","journal-title":"Cancer Res."},{"key":"BFncomms3697_CR6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nrc2012","volume":"6","author":"F Toledo","year":"2008","unstructured":"Toledo, F. & Wahl, G. M. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 6, 909\u2013923 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms3697_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","volume":"91","author":"T Kamijo","year":"1997","unstructured":"Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649\u2013659 (1997).","journal-title":"Cell"},{"key":"BFncomms3697_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.molcel.2006.01.020","volume":"21","author":"CL Brooks","year":"2006","unstructured":"Brooks, C. L. & Gu, W. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21, 307\u2013315 (2006).","journal-title":"Mol. Cell"},{"key":"BFncomms3697_CR9","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.1073\/pnas.95.14.8292","volume":"95","author":"T Kamijo","year":"1998","unstructured":"Kamijo, T. et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA 95, 8292\u20138297 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms3697_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","volume":"92","author":"J Pomerantz","year":"1998","unstructured":"Pomerantz, J. et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713\u2013723 (1998).","journal-title":"Cell"},{"key":"BFncomms3697_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1172\/JCI20761","volume":"113","author":"NE Sharpless","year":"2004","unstructured":"Sharpless, N. E. & DePinho, R. A. Telomeres, stem cells, senescence, and cancer. J. Clin. Invest. 113, 160\u2013168 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFncomms3697_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1101\/sqb.2005.70.004","volume":"70","author":"CJ Sherr","year":"2005","unstructured":"Sherr, C. J. et al. p53-Dependent and -independent functions of the Arf tumor suppressor. Cold Spring Harb. Symp. Quant. Biol. 70, 129\u2013137 (2005).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"BFncomms3697_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini, S., Gorgoulis, V. G. & Halazonetis, T. D. Genomic instability - an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11, 220\u2013228 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFncomms3697_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature05268","volume":"444","author":"J Bartkova","year":"2006","unstructured":"Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633\u2013637 (2006).","journal-title":"Nature"},{"key":"BFncomms3697_CR15","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.1140735","volume":"319","author":"TD Halazonetis","year":"2008","unstructured":"Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352\u20131355 (2008).","journal-title":"Science"},{"key":"BFncomms3697_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1101\/gad.2021311","volume":"25","author":"SE Polo","year":"2011","unstructured":"Polo, S. E. & Jackson, S. P. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 25, 409\u2013433 (2011).","journal-title":"Genes Dev."},{"key":"BFncomms3697_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cell.2011.03.041","volume":"145","author":"K Schlacher","year":"2011","unstructured":"Schlacher, K. et al. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 145, 529\u2013542 (2011).","journal-title":"Cell"},{"key":"BFncomms3697_CR18","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nsmb.1927","volume":"17","author":"Y Hashimoto","year":"2010","unstructured":"Hashimoto, Y., Ray Chaudhuri, A., Lopes, M. & Costanzo, V. Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis. Nat. Struct. Mol. Biol. 17, 1305\u20131311 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFncomms3697_CR19","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1038\/sj.onc.1209871","volume":"25","author":"B Evers","year":"2006","unstructured":"Evers, B. & Jonkers, J. Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene 25, 5885\u20135897 (2006).","journal-title":"Oncogene"},{"key":"BFncomms3697_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev.pathol.3.121806.151422","volume":"4","author":"AR Venkitaraman","year":"2009","unstructured":"Venkitaraman, A. R. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu. Rev. Pathol. 4, 461\u2013487 (2009).","journal-title":"Annu. Rev. Pathol."},{"key":"BFncomms3697_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/ng747","volume":"29","author":"J Jonkers","year":"2001","unstructured":"Jonkers, J. et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29, 418\u2013425 (2001).","journal-title":"Nat. Genet."},{"key":"BFncomms3697_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1097-2765(01)00295-7","volume":"8","author":"DP Silver","year":"2001","unstructured":"Silver, D. P. & Livingston, D. M. Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol. Cell 8, 233\u2013243 (2001).","journal-title":"Mol. Cell"},{"key":"BFncomms3697_CR23","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","volume":"64","author":"I Hickson","year":"2004","unstructured":"Hickson, I. et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64, 9152\u20139159 (2004).","journal-title":"Cancer Res."},{"key":"BFncomms3697_CR24","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","volume":"17","author":"FJ Stott","year":"1998","unstructured":"Stott, F. J. et al. The alternative product from the human CDKN2A locus, p14 ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001\u20135014 (1998).","journal-title":"EMBO J."},{"key":"BFncomms3697_CR25","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1073\/pnas.97.7.3266","volume":"97","author":"SH Khan","year":"2000","unstructured":"Khan, S. H., Moritsugu, J. & Wahl, G. M. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion. Proc. Natl Acad. Sci. USA 97, 3266\u20133271 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms3697_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/ncb1337","volume":"8","author":"A Jazayeri","year":"2006","unstructured":"Jazayeri, A. et al. ATM- and cell cycle dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8, 37\u201345 (2006).","journal-title":"Nat. Cell Biol."},{"key":"BFncomms3697_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.dnarep.2010.12.004","volume":"10","author":"EP Mimitou","year":"2011","unstructured":"Mimitou, E. P. & Symington, L. S. DNA end resection-Unraveling the tail. DNA Rep. (Amst.) 10, 344\u2013348 (2011).","journal-title":"DNA Rep. (Amst.)"},{"key":"BFncomms3697_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.molcel.2012.02.015","volume":"46","author":"SF Bunting","year":"2012","unstructured":"Bunting, S. F. et al. BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol. Cell 46, 125\u2013135 (2012).","journal-title":"Mol. Cell"},{"key":"BFncomms3697_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nchembio.63","volume":"4","author":"A Dupr\u00e9","year":"2008","unstructured":"Dupr\u00e9, A. et al. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat. Chem. Biol. 4, 119\u2013125 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"BFncomms3697_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrm1127","volume":"4","author":"SC West","year":"2003","unstructured":"West, S. C. Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol. 4, 1\u201311 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFncomms3697_CR31","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/nsmb.1943","volume":"17","author":"S Badie","year":"2010","unstructured":"Badie, S. et al. BRCA2 acts as RAD51 loader to facilitate telomere replication and capping. Nat. Struct. Mol. Biol. 17, 1461\u20131469 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFncomms3697_CR32","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1021\/jm101488z","volume":"54","author":"JD Charrier","year":"2011","unstructured":"Charrier, J. D. et al. Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents. J. Med. Chem. 54, 2320\u20132330 (2011).","journal-title":"J. Med. Chem."},{"key":"BFncomms3697_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1172\/JCI58928","volume":"122","author":"DW Schoppy","year":"2011","unstructured":"Schoppy, D. W. et al. Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR. J. Clin. Invest. 122, 241\u2013252 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFncomms3697_CR34","doi-asserted-by":"publisher","first-page":"9693","DOI":"10.1158\/0008-5472.CAN-10-2286","volume":"70","author":"O Gilad","year":"2010","unstructured":"Gilad, O. et al. Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner. Cancer Res. 70, 9693\u20139702 (2010).","journal-title":"Cancer Res."},{"key":"BFncomms3697_CR35","first-page":"1833","volume":"15","author":"WC Lin","year":"2001","unstructured":"Lin, W. C., Lin, F. T. & Nevins, J. R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15, 1833\u20131844 (2001).","journal-title":"Genes Dev."},{"key":"BFncomms3697_CR36","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nature08820","volume":"464","author":"D Chen","year":"2010","unstructured":"Chen, D., Shan, J., Zhu, W. G., Qin, J. & Gu, W. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses. Nature 464, 624\u2013627 (2010).","journal-title":"Nature"},{"key":"BFncomms3697_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden, K. H. & Prives, C. Blinded by the light: the growing complexity of p53. Cell 137, 413\u2013431 (2009).","journal-title":"Cell"},{"key":"BFncomms3697_CR38","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","volume":"13","author":"CJ Sherr","year":"1999","unstructured":"Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501\u20131512 (1999).","journal-title":"Genes Dev."},{"key":"BFncomms3697_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10555-008-9123-1","volume":"27","author":"SM Keyse","year":"2008","unstructured":"Keyse, S. M. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 27, 253\u2013261 (2008).","journal-title":"Cancer Metastasis Rev."},{"key":"BFncomms3697_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd2289","volume":"6","author":"KL Jeffrey","year":"2007","unstructured":"Jeffrey, K. L., Camps, M., Rommel, C. & Mackay, C. R. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat. Rev. Drug Discov. 6, 391\u2013403 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFncomms3697_CR41","doi-asserted-by":"publisher","first-page":"13920","DOI":"10.1073\/pnas.96.24.13920","volume":"96","author":"BH Spain","year":"1999","unstructured":"Spain, B. H., Larson, C. J., Shihabuddin, L. S., Gage, F. H. & Verma, I. M. Truncated BRCA2 is cytoplasmic: Implications for cancer-linked mutations. Proc. Natl Acad. Sci. USA 96, 13920\u201313925 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms3697_CR42","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434, 913\u2013917 (2005).","journal-title":"Nature"},{"key":"BFncomms3697_CR43","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nature03485","volume":"434","author":"VG Gorgoulis","year":"2005","unstructured":"Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907\u2013913 (2005).","journal-title":"Nature"},{"key":"BFncomms3697_CR44","first-page":"2464","volume":"59","author":"T Kamijo","year":"1999","unstructured":"Kamijo, T. et al. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled Atm Function1. Cancer Res. 59, 2464\u20132469 (1999).","journal-title":"Cancer Res."},{"key":"BFncomms3697_CR45","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb1024","volume":"5","author":"S Parrinello","year":"2003","unstructured":"Parrinello, S. et al. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol. 5, 741\u2013747 (2003).","journal-title":"Nat. Cell Biol."},{"key":"BFncomms3697_CR46","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cell.2009.04.050","volume":"137","author":"JP Kruse","year":"2009","unstructured":"Kruse, J. P. & Gu, W. Modes of p53 regulation. Cell 137, 609\u2013622 (2009).","journal-title":"Cell"},{"key":"BFncomms3697_CR47","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ncb2852","volume":"15","author":"G Velimezi","year":"2013","unstructured":"Velimezi, G. et al. Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer. Nat. Cell Biol. 15, 1260 (2013).","journal-title":"Nat. Cell Biol."},{"key":"BFncomms3697_CR48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature05077","volume":"443","author":"MA Christophorou","year":"2006","unstructured":"Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B. & Evan, G. I. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443, 214\u2013217 (2006).","journal-title":"Nature"},{"key":"BFncomms3697_CR49","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0140-6736(05)63327-2","volume":"350","author":"T Crook","year":"1997","unstructured":"Crook, T., Crossland, S., Crompton, M. R., Osin, P. & Gusterson, B. A. p53 mutations in BRCA1-associated familial breast cancer. Lancet 350, 638\u2013639 (1997).","journal-title":"Lancet"},{"key":"BFncomms3697_CR50","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1158\/0008-5472.CAN-03-2270","volume":"64","author":"AM Cheung","year":"2004","unstructured":"Cheung, A. M. et al. Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+\/\u2212) mutant mice. Cancer Res. 64, 1959\u20131965 (2004).","journal-title":"Cancer Res."},{"key":"BFncomms3697_CR51","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrc1954","volume":"6","author":"CJ Sherr","year":"2006","unstructured":"Sherr, C. J. Divorcing ARF and p53: an unsettled case. Nat. Rev. Cancer 6, 663\u2013673 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms3697_CR52","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/nm.2795","volume":"18","author":"JM Balko","year":"2012","unstructured":"Balko, J. M. et al. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Nat. Med. 18, 1052\u20131059 (2012).","journal-title":"Nat. Med."},{"key":"BFncomms3697_CR53","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917\u2013921 (2005).","journal-title":"Nature"},{"key":"BFncomms3697_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner, E. F. & Nebreda, A. R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537\u2013549 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms3697_CR55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215\u2013221 (1992).","journal-title":"Nature"},{"key":"BFncomms3697_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0092-8674(01)80006-4","volume":"91","author":"MA Blasco","year":"1997","unstructured":"Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25\u201334 (1997).","journal-title":"Cell"},{"key":"BFncomms3697_CR57","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0076-6879(01)33060-4","volume":"333","author":"I Palmero","year":"2001","unstructured":"Palmero, I. & Serrano, M. Induction of senescence by oncogenic Ras. Methods Enzymol. 333, 247\u2013256 (2001).","journal-title":"Methods Enzymol."},{"key":"BFncomms3697_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0092-8674(04)00337-X","volume":"117","author":"M Tarsounas","year":"2004","unstructured":"Tarsounas, M. et al. Telomere maintenance requires the RAD51D recombination\/repair protein. Cell 117, 337\u2013347 (2004).","journal-title":"Cell"},{"key":"BFncomms3697_CR59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature01764","volume":"424","author":"J Sage","year":"2003","unstructured":"Sage, J., Miller, A. L., P\u00e9rez-Mancera, P. A., Wysocki, J. M. & Jacks, T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223\u2013228 (2003).","journal-title":"Nature"},{"key":"BFncomms3697_CR60","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/nature06065","volume":"448","author":"EL Denchi","year":"2007","unstructured":"Denchi, E. L. & de Lange, T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448, 1068\u20131071 (2007).","journal-title":"Nature"},{"key":"BFncomms3697_CR61","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463\u20138471 (1998).","journal-title":"J. Virol."},{"key":"BFncomms3697_CR62","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nature08196","volume":"460","author":"Y Deng","year":"2009","unstructured":"Deng, Y., Guo, X., Ferguson, D. O. & Chang, S. Multiple roles for MRE11 at uncapped telomeres. Nature 460, 914\u2013918 (2009).","journal-title":"Nature"},{"key":"BFncomms3697_CR63","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1093\/nar\/gks068","volume":"40","author":"A Bugaut","year":"2012","unstructured":"Bugaut, A. & Balasubramanian, S. 5\u2032-UTR RNA G-quadruplexes: translation regulation and targeting. Nucleic Acids Res. 40, 4727\u20134741 (2012).","journal-title":"Nucleic Acids Res."},{"key":"BFncomms3697_CR64","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363\u20139367 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms3697_CR65","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1083\/jcb.140.6.1285","volume":"40","author":"DA Jackson","year":"1998","unstructured":"Jackson, D. A. & Pombo, A. Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. J. Cell Biol. 40, 1285\u20131295 (1998).","journal-title":"J. Cell Biol."},{"key":"BFncomms3697_CR66","doi-asserted-by":"crossref","unstructured":"Lin, S. M., Du, P., Huber, W. & Kibbe, W. A. Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res. 36, (2008).","DOI":"10.1093\/nar\/gkm1075"},{"key":"BFncomms3697_CR67","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/bioinformatics\/bti270","volume":"21","author":"GK Smyth","year":"2005","unstructured":"Smyth, G. K., Michaud, J. & Scott, H. S. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21, 2067\u20132075 (2005).","journal-title":"Bioinformatics"},{"key":"BFncomms3697_CR68","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/sj.onc.1206263","volume":"22","author":"M Tarsounas","year":"2003","unstructured":"Tarsounas, M., Davies, D. & West, S. C. BRCA2-dependent and independent formation of RAD51 nuclear foci. Oncogene 22, 1115\u20131123 (2003).","journal-title":"Oncogene"},{"key":"BFncomms3697_CR69","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1074\/jbc.M111.278994","volume":"287","author":"J Min","year":"2012","unstructured":"Min, J. et al. The breast cancer susceptibility gene BRCA2 is required for the maintenance of telomere homeostasis. J. Biol. Chem. 287, 5091\u20135101 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFncomms3697_CR70","doi-asserted-by":"publisher","first-page":"22315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NAP Franken","year":"2006","unstructured":"Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 1, 22315\u201322319 (2006).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms3697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms3697","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms3697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T01:17:29Z","timestamp":1672967849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms3697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,28]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,20]]}},"alternative-id":["BFncomms3697"],"URL":"https:\/\/doi.org\/10.1038\/ncomms3697","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,28]]},"assertion":[{"value":"27 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2697"}}